2022年当代简明综述:睡眠
该综述汇总新冠与睡眠、阻塞性睡眠呼吸暂停(OSA)及失眠领域进展:疫情期间失眠与睡眠质量下降增多,医护人员尤易受累且认知行为治疗失眠(CBT-I)可改善;长新冠对睡眠有显著影响,OSA影响急性新冠病情严重程度;临床代表性患者的大型试验证实CPAP的心血管获益。
要点
- 医护人员疫情期间失眠易感,CBT-I可改善其睡眠。
- 大型试验证实CPAP治疗OSA的心血管获益。
- 失眠与OSA常共存(COMISA),联合危害心血管健康。
核心结论
- 疫情期间失眠与睡眠质量下降增多,医护人员尤其易感,CBT-I可改善。
- 大型临床试验证实CPAP治疗OSA具有心血管获益。
研究设计与样本
- 综述,未报告检索范围与样本量。
主要发现
- 长新冠对睡眠有显著影响,OSA影响急性新冠病情严重程度。
- CPAP可能改善OSA长期认知结局,但需进一步研究。
- OSA患病率与死亡风险存在种族差异,且逐渐显现。
- 孕期应定期评估OSA风险,时机可能对干预心血管危险因素关键。
- 失眠与OSA常共存(COMISA),两者叠加的负面影响可能有害,尤其对心血管健康。
关键数值与推荐
- 新型食欲素受体拮抗剂治疗失眠有有效性证据。
临床怎么用
- 对医护人员失眠可采用CBT-I干预。
- 对OSA患者应重视CPAP心血管获益并关注长期认知结局。
- 对孕期人群定期评估OSA风险以把握干预时机。
局限性
- 综述未报告检索范围、样本量等,证据细节有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
COVID-19 AND SLEEP: The COVID-19 pandemic is associated with an increase in insomnia and impaired sleep quality Health care workers are particularly susceptible and improved with cognitive behavioural therapy for insomnia (CBT-I) Long COVID has significant effects on sleep OSA impacts on the severity of acute COVID-19 illness OBSTRUCTIVE SLEEP APNOEA: Large trials of clinically representative patients confirm the cardiovascular benefits of CPAP treatment in OSA CPAP may improve long-term cognitive outcomes in OSA, but further research is needed Racial disparities in OSA prevalence and mortality risk are becoming evident Periodic evaluation of OSA risk in pregnancy is important as timing may be key for intervention to prevent or treat cardiovascular risk factors INSOMNIA: Comorbid insomnia and obstructive sleep apnoea (COMISA) can frequently co-exist and the combined negative effects of both may be deleterious, particularly to cardiovascular health There is evidence for effectiveness with novel orexin receptor antagonists.
引用
- O'Driscoll DM, Young AC. Contemporary Concise Review 2022: Sleep. Respirology. 2023. PMID: 36990762. doi:10.1111/resp.14500
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。